Decibel Cannabis Company (TSE:DB)
:DB
Want to see TSE:DB full AI Analyst Report?
Top Page
Decibel Cannabis Company
(DB)
Select Model
Select Model
Rating:48Neutral
Price Target:
C$0.13
▲(29.00% Upside)
Action:Reiterated
Date:05/23/26
The score is held back primarily by weak financial performance—especially the deterioration to negative operating/free cash flow and continued net losses—despite improved revenue and EBITDA. Technical indicators are moderately supportive with price above key moving averages and neutral-to-positive momentum, but valuation remains constrained by negative earnings and no dividend.
Positive Factors
Revenue growth & EBITDA recovery
Revenue and margin recovery with EBITDA returning to positive territory indicates the business can scale profitably at current volumes. This durability suggests operational improvements and pricing/product mix benefits that support sustainable cash generation if trends continue.
Negative Factors
Negative operating & free cash flow
Recent reversal to negative operating and free cash flow increases funding risk and constrains internal reinvestment. Persistent cash burn would force reliance on external financing, dilutive capital raises, or cost cuts, impeding long-term strategic execution and growth initiatives.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue growth & EBITDA recovery
Revenue and margin recovery with EBITDA returning to positive territory indicates the business can scale profitably at current volumes. This durability suggests operational improvements and pricing/product mix benefits that support sustainable cash generation if trends continue.
Read all positive factors
Decibel Cannabis Company (DB) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$69.23M
Dividend YieldN/A
Average Volume (3M)258.21K
Price to Earnings (P/E)―
Beta (1Y)0.28
Revenue Growth30.71%
EPS Growth-123.40%
CountryCA
Employees171
SectorHealthcare
Sector Strength45
IndustryDrug Manufacturers - Specialty & Generic
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding576,900,000
10 Day Avg. Volume297,792
30 Day Avg. Volume258,209
Financial Highlights & Ratios
PEG Ratio0.18
Price to Book (P/B)1.02
Price to Sales (P/S)0.56
P/FCF Ratio11.59
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$0.27Price Target Upside166.67% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)0.02
Revenue Forecast (FY)C$131.20M
Decibel Cannabis Company Business Overview & Revenue Model
Company Description
Decibel Cannabis Company Inc. engages in the cultivation, processing, production, and retail sale of cannabis products in Canada. It offers cannabis flower, cannabis pre-rolls, and cannabis biomass to licensed producers in Canada. The company is a...
How the Company Makes Money
Decibel Cannabis Company makes money primarily by selling finished cannabis products into Canada’s regulated legal market. Its core revenue streams generally include: (1) wholesale sales of branded cannabis products (e.g., dried flower and other f...
Decibel Cannabis Company Financial Statement Overview
Summary
Income Statement
49
Neutral
Balance Sheet
56
Neutral
Cash Flow
33
Negative
| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 112.72M | 92.54M | 106.22M | 79.33M | 52.45M |
| Gross Profit | 17.49M | 37.58M | 38.77M | 26.43M | 28.17M |
| EBITDA | -10.80M | 21.53M | 3.25M | 2.26M | 9.45M |
| Net Income | -2.92M | 9.46M | -1.77M | -4.46M | 1.74M |
Balance Sheet | |||||
| Total Assets | 141.60M | 151.86M | 142.99M | 140.88M | 125.93M |
| Cash, Cash Equivalents and Short-Term Investments | 7.49M | 7.00M | 3.48M | 2.97M | 1.92M |
| Total Debt | 44.16M | 48.32M | 48.52M | 48.39M | 49.90M |
| Total Liabilities | 79.25M | 87.14M | 96.79M | 93.67M | 75.19M |
| Stockholders Equity | 62.35M | 64.72M | 46.20M | 47.21M | 50.73M |
Cash Flow | |||||
| Free Cash Flow | 5.47M | 3.21M | 4.92M | 4.44M | -20.39M |
| Operating Cash Flow | 7.46M | 3.98M | 7.08M | 8.26M | -17.15M |
| Investing Cash Flow | -1.98M | 1.19M | -2.13M | -3.76M | -3.23M |
| Financing Cash Flow | -4.98M | -1.65M | -4.43M | -3.45M | 18.47M |
Decibel Cannabis Company Technical Analysis
Negative
0.10
Price Trends
0.13
Negative
0.11
Positive
0.12
Positive
Market Momentum
>-0.01
Positive
43.85
Neutral
54.17
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:DB, the sentiment is Negative. The current price of 0.1 is below the 20-day moving average (MA) of 0.12, below the 50-day MA of 0.13, and below the 200-day MA of 0.12, indicating a neutral trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 43.85 is Neutral, neither overbought nor oversold. The STOCH value of 54.17 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:DB.
Decibel Cannabis Company Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
56 Neutral | C$31.86M | -3.64 | -19.10% | ― | 0.66% | -14.29% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
48 Neutral | C$69.23M | -21.64 | 12.78% | ― | 30.71% | -123.40% | |
46 Neutral | C$112.42M | -2.21 | -2065.45% | ― | -2.64% | -36.69% | |
46 Neutral | C$69.01M | -0.68 | -112.30% | ― | -21.09% | -54.32% | |
43 Neutral | C$61.68M | -2.31 | 136.59% | ― | ― | ― | |
41 Neutral | C$22.58M | -90.11 | -2.15% | ― | 24.10% | 94.52% |
* Healthcare Sector Average
TSE:DB
Decibel Cannabis Company
0.12
0.05
84.62%
TSE:LEEF
Leef Brands
0.23
>-0.01
-2.17%
TSE:CWEB
Charlotte's Web Holdings
0.67
0.53
378.57%
TSE:LABS
MediPharm Labs
0.08
0.00
0.00%
TSE:PLTH
Planet 13 Holdings
0.22
-0.08
-28.33%
TSE:GWAY
Greenway Greenhouse Cannabis Corp.
0.15
-0.06
-27.50%
Decibel Cannabis Company Corporate Events
Financial Disclosures
Decibel Cannabis to Release Q4 2025 Results on April 16, 2026
Neutral
Apr 8, 2026
Decibel Cannabis Company plans to release its fourth quarter 2025 financial results before markets open on April 16, 2026, and will hold a conference call later that morning to discuss its performance. The announcement signals an upcoming update o...
Business Operations and StrategyM&A Transactions
Decibel to Sell Creston Site and Consolidate Cannabis Cultivation for Efficiency Gains
Positive
Feb 25, 2026
Decibel Cannabis Company Inc. has agreed to sell its Creston, British Columbia property for about $2.5 million and will use the proceeds to repay a portion of its recently announced term debt. As part of the move, the company will consolidate cult...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.